Haoxi Health Technology Limited
January 24, 2024
Via EDGAR
Division of Corporation Finance
Office of Manufacturing
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C., 20549
| Attention: | Robert Shapiro |
| Doug Jones | |
| Nicholas Nalbantian | |
| Erin Jaskot |
| Re: | Haoxi Health Technology Limited |
| Registration Statement on Form F-1, as amended | |
| Initially Filed on August 25, 2023 | |
| File No. 333-274214 |
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Haoxi Health Technology Limited hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, be accelerated to and that the Registration Statement become effective at 4.00 p.m., Eastern Time, on January 25, 2024, or as soon thereafter as practicable.
| Very truly yours, | |||
| Haoxi Health Technology Limited | |||
| By: | /s/ Fan Zhen | ||
| Name: | Fan Zhen | ||
| Title: | Chief Executive Officer, Director | ||